Page 65 - ESGO - Vulvar cancer - Complete report_fxd2
P. 65
260. Bafna, U.D., et al. Carcinoma of the vulva: 267. Witteveen, P.O., et al. Phase II study on
a retrospective review of 37 cases at a paclitaxel in patients with recurrent,
regional cancer centre in South India. J metastatic or locally advanced vulvar
Obstet Gynaecol 24, 403-407 (2004). cancer not amenable to surgery or
radiotherapy: a study of the EORTC-GCG
261. Geisler, J.P., Manahan, K.J. & Buller, R.E. (European Organisation for Research and
Neoadjuvant chemotherapy in vulvar Treatment of Cancer--Gynaecological
cancer: avoiding primary exenteration. Cancer Group). Ann Oncol 20, 1511-1516
Gynecol Oncol 100, 53-57 (2006). (2009).
262. Domingues, A.P., et al. Neoadjuvant 268. Thigpen, J.T., Blessing, J.A., Homesley,
chemotherapy in advanced vulvar cancer. H.D. & Lewis, G.C., Jr. Phase II trials of
Int J Gynecol Cancer 20, 294-298 (2010). cisplatin and piperazinedione in advanced
or recurrent squamous cell carcinoma of
263. Aragona, A.M., et al. Tailoring the the vulva: a Gynecologic Oncology Group
treatment of locally advanced squamous Study. Gynecol Oncol 23, 358-363 (1986).
cell carcinoma of the vulva: neoadjuvant
chemotherapy followed by radical surgery: 269. Cormio, G., et al. Cisplatin and
results from a multicenter study. Int J vinorelbine chemotherapy in recurrent
Gynecol Cancer 22, 1258-1263 (2012). vulvar carcinoma. Oncology 77, 281-284
(2009).
264. Han, S.N., Vergote, I. & Amant, F.
Weekly paclitaxel/carboplatin in the 270. Muss, H.B., Bundy, B.N. &
treatment of locally advanced, recurrent, or Christopherson, W.A. Mitoxantrone in the
metastatic vulvar cancer. Int J Gynecol treatment of advanced vulvar and vaginal
Cancer 22, 865-868 (2012). carcinoma. A gynecologic oncology group
study. Am J Clin Oncol 12, 142-144
265. Bellati, F., et al. Single agent cisplatin (1989).
chemotherapy in surgically resected vulvar
cancer patients with multiple inguinal 271. Salani, R., et al. Posttreatment surveillance
lymph node metastases. Gynecol Oncol 96,
227-231 (2005). and diagnosis of recurrence in women with
266. Horowitz, N.S., et al. Phase II trial of gynecologic malignancies: Society of
erlotinib in women with squamous cell
carcinoma of the vulva. Gynecol Oncol Gynecologic Oncologists
127, 141-146 (2012).
recommendations. Am J Obstet Gynecol
204, 466-478 (2011).
VULVAR CANCER - GUIDELINES
65
